AAAAAA

   
Results: 1-25 | 26-50 | 51-75
Results: 26-50/75

Authors: Fujimoto, J Hirose, R Sakaguchi, H Tamaya, T
Citation: J. Fujimoto et al., Clinical significance of expression of estrogen receptor alpha and beta mRNAs in ovarian cancers, ONCOL-BASEL, 58(4), 2000, pp. 334-341

Authors: Misao, R Nakanishi, Y Sun, WS Iwagaki, S Fujimoto, J Tamaya, T
Citation: R. Misao et al., Identification of exon-deleted progesterone receptor mRNAs in human uterine endometrial cancers, ONCOL-BASEL, 58(1), 2000, pp. 60-65

Authors: Imai, A Furui, T Tamaya, T Mills, GB
Citation: A. Imai et al., A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within time plasma membrane of ovarian cancer cells, J CLIN END, 85(9), 2000, pp. 3370-3375

Authors: Mikamo, H Hua, YX Hayasaki, Y Satoh, M Kai, J Tamaya, T
Citation: H. Mikamo et al., In vitro bactericidal activity and morphologic change in Bacteroides fragilis and Prevotella bivia with azithromycin, CURR THER R, 61(8), 2000, pp. 549-552

Authors: Mikamo, H Sato, Y Hayasaki, Y Tamaya, T
Citation: H. Mikamo et al., Current status and fluconazole treatment of pelvis fungal gynecological infections, CHEMOTHERA, 46(3), 2000, pp. 209-212

Authors: Mikamo, H Sato, Y Hayasaki, Y Tamaya, T
Citation: H. Mikamo et al., In vitro and in vivo antibacterial activities of biapenem in the fields ofobstetrics and gynecology, CHEMOTHERA, 46(2), 2000, pp. 95-99

Authors: Mikamo, H Sato, Y Hayasaki, Y Hua, YX Tamaya, T
Citation: H. Mikamo et al., Adequate levofloxacin treatment schedules for uterine cervicitis caused byChlamydia trachomatis, CHEMOTHERA, 46(2), 2000, pp. 150-152

Authors: Fujimoto, J Sakaguchi, H Aoki, I Tamaya, T
Citation: J. Fujimoto et al., The value of platelet-derived endothelial cell growth factor as a novel predictor of advancement of uterine cervical cancers, CANCER RES, 60(13), 2000, pp. 3662-3665

Authors: Fujimoto, J Sakaguchi, H Aoki, I Tamaya, T
Citation: J. Fujimoto et al., Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers, CANCER RES, 60(10), 2000, pp. 2632-2635

Authors: Yokoyama, Y Takahashi, Y Shinohara, A Wan, XY Takahashi, S Niwa, K Tamaya, T
Citation: Y. Yokoyama et al., The 5 '-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity, BIOC BIOP R, 273(1), 2000, pp. 316-321

Authors: Imai, A Takagi, A Tamaya, T
Citation: A. Imai et al., Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro, AM J OBST G, 182(5), 2000, pp. 1142-1146

Authors: Imai, A Takagi, H Takagi, A Tamaya, T
Citation: A. Imai et al., Phosphatidylinositol kinase activity in ovarian cancer cells, METH MOL M, 39, 2000, pp. 589-596

Authors: Imai, A Horibe, S Takagi, A Tamaya, T
Citation: A. Imai et al., Phosphotyrosine phosphatase activity in ovarian carcinoma cells - Stimulation by GnRH in plasma membrane, METH MOL M, 39, 2000, pp. 601-605

Authors: Fujimoto, J Hirose, R Sakaguchi, H Tamaya, T
Citation: J. Fujimoto et al., Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata, MOL HUM REP, 5(8), 1999, pp. 742-747

Authors: Misao, R Nakanishi, Y Sun, WS Fujimoto, J Iwagaki, S Hirose, R Tamaya, T
Citation: R. Misao et al., Expression of oestrogen receptor alpha and beta mRNA in corpus luteum of human subjects, MOL HUM REP, 5(1), 1999, pp. 17-21

Authors: Misao, R Iwagaki, S Sun, WS Fujimoto, J Tamaya, T
Citation: R. Misao et al., Levels of corticosteroid-binding globulin mRNA in human ovarian cancers, TUMOR BIOL, 20(5), 1999, pp. 263-269

Authors: Misao, R Iwagaki, S Fujimoto, J Nakanishi, Y Sun, WS Tamaya, T
Citation: R. Misao et al., Expression of sex hormone-binding globulin exon 7 splicing variant mRNA insecondary spreading lesions of gynecological cancers, J STEROID B, 68(3-4), 1999, pp. 103-109

Authors: Misao, R Nakanishi, Y Fujimoto, J Iwagaki, S Tamaya, T
Citation: R. Misao et al., Levels of sex hormone-binding globulin and corticosteroid-binding globulinmRNAs in corpus luteum of human subjects: correlation with serum steroid hormone levels, GYNECOL END, 13(2), 1999, pp. 82-88

Authors: Imai, A Takagi, A Tamaya, T
Citation: A. Imai et al., A novel sex-determining region on Y (SRY) missense mutation identified in a 46,XY female and also in the father, ENDOCR J, 46(5), 1999, pp. 735-739

Authors: Niwa, K Hashimoto, M Morishita, S Yokoyama, Y Mori, H Tamaya, T
Citation: K. Niwa et al., Preventive effects of Glycyrrhizae radix extract on estrogen-related endometrial carcinogenesis in mice, JPN J CANC, 90(7), 1999, pp. 726-732

Authors: Fujimoto, J Sakaguchi, H Hirose, R Wen, HW Tamaya, T
Citation: J. Fujimoto et al., Angiogenesis in endometriosis and angiogenic factors, GYNECOL OBS, 48, 1999, pp. 14-18

Authors: Niwa, K Murase, T Morishita, S Hashimoto, M Itoh, N Tamaya, T
Citation: K. Niwa et al., p53 overexpression and mutation in endometrial carcinoma: Inverted relation with estrogen and progesterone receptor status, CANCER DET, 23(2), 1999, pp. 147-154

Authors: Fujimoto, J Sakaguchi, H Hirose, R Ichigo, S Tamaya, T
Citation: J. Fujimoto et al., Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells, CANCER LETT, 141(1-2), 1999, pp. 63-71

Authors: Matsunami, K Imai, A Tamaya, T Takagi, H Noda, K
Citation: K. Matsunami et al., Brain metastasis as first manifestation of ovarian cancer, EUR J OB GY, 82(1), 1999, pp. 81-83

Authors: Misao, R Iwagaki, S Fujimoto, J Sun, WS Tamaya, T
Citation: R. Misao et al., Dominant expression of progesterone receptor form B mRNA in ovarian endometriosis, HORMONE RES, 52(1), 1999, pp. 30-34
Risultati: 1-25 | 26-50 | 51-75